Trial Profile
Clinical study of calcium channel blockers in patients with chronic kidney disease.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 22 May 2015
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Azelnidipine (Primary) ; Benidipine (Primary) ; Cilnidipine (Primary)
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 04 Nov 2009 New trial record